Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
SOLENO THERAPEUTICS INC (SLNO)
|
|
Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues | | | | | | | | 100.0% |
Cost of goods sold | | | | | | | | 58.1% |
Gross profit | | | | | | | | 41.9% |
Sales and marketing | | | | | | | | 286.0% |
Research and development | | | | | | | | 746.7% |
General and administrative | | | | | | | | 1010.9% |
Depreciation | | | | | | | | 17.8% |
EBIT | | | | | | | | -2031.9% |
Pre-tax income | | | | | | | | -2618.8% |
Income taxes | | | | | | | | 0.0% |
Net income | | | | | | | | -2618.8% |
|